About This Role
Associate Director, Global Price & Access will help to develop and execute the global pricing, reimbursement and market access strategy for our future broader Nephrology portfolio. The Associate Director/Senior Manager, Global Price & Access (Pricing and Reimbursement) will be responsible for supporting the ongoing reimbursement/launch preparation in US, EU, and international markets. The individual will help to lead key global P&RS initiatives such as global pricing policy, pricing communications, value proposition and messages, detailed forecast assumptions, global price bands and launch sequence, support strategies with in-depth market research, environmental data & analogs.
Additional focus will be to support LCM activities for nephrology, including providing input to new indication expansion business cases, Phase 3 trials, LTE and biomarker studies. Ability to collaborate with Cross-Functional colleagues, regional and US MAx leads will be imperative to ensure a successful launch across indications/affiliates.
What You’ll Do
- Conduct secondary research determining price levels of existing therapies and payer management, HTA review outcomes for relevant products, and burden of disease to inform price and market access estimates, inform target product profile and clinical trials development program;
- Lead third party abbreviated payer and analog research, integrating product’s value proposition and supporting clinical information, to determine achievable price, including gross to net, and market access for specific (or, across) indication(s), and optimal evidence package and indication sequencing
- Develop pricing, market access, and gross-to-net assumptions for the forecast (SFT) and financial model quantifying the business opportunity as part of the indication(s) commercial evaluation.
- Help to lead the development of Pricing and Reimbursement (P&R) strategies and management of Market Access strategies throughout the life cycle
- Contribute to cross-functional decisions for launch and lifecycle P&R strategies by proposing price/access positions, country price targets, regional price guardrails and launch sequences
- Develop value-driven optimal pricing strategies for markets including value-based contracting, tendering, etc. to ensure market access throughout the life cycle
- Develop and deliver innovative pricing strategies, including contracting/tendering frameworks, risk sharing programs, and portfolio strategies where appropriate;
- Post launch, collaborate with Regional and Local MAx teams to support recurring payer reimbursement reviews and to evaluate country price exceptions to global pricing corridors and policies;
- Develop a productive relationship and integration with other Value & Access functions to seamlessly deliver market access support globally, regionally, and locally;
- Identify environmental issues and long range planning assessments, including expert point of view on P&R system reforms and evolving competitive access landscapes;
- Point of accountability to select PDC indication specific sub-team(s) and Commercial Team(s) for overall pricing and reimbursement strategies within the Nephrology Franchise;
- Provide P&R input into licensing and business development assessments within Nephrology, if required, at appropriate due diligence stages;
- Identification of relevant price benchmarks and price potential in the future nephrology product pipeline in terms of a value proposition as well as the market need compared to existing or upcoming therapeutic alternatives in the respective indications.
- Represent the Biogen Value & Access function externally at P&R and policy related forums to influence and further the science;
- Ensure compliance with legal requirements.
Who You Are
- You are passionate about learning about different diseases and therapeutic areas and enjoy assessing how an asset’s value proposition will be valued and reimbursed at different key strategic markets.
- You are comfortable developing price and access estimates working with limited information and through a rigorous iterative process to understand disease, value proposition, and price opportunity for asset.
- You are comfortable working with a small team, dynamic environment and excited about working on a matrix.
Required Skills:
- Bachelors, Master’s or doctorate in a related economic, scientific, or business discipline.
- 7+ years of relevant pricing and access experience, including a strong understanding of the payer environment globally.
- Experience in developing global payer policy and strategies.
- Demonstrated expertise in pharmaceutical product development or commercialization.
- Strong communication and influencing skills.
- Ability to work effectively under pressure and within short timeframes.
Preferred Skills:
- Experience with innovative contracting proposals.
- Knowledge of health technologies assessment and health policy.
- Proven track record of developing therapeutic expertise.
Additional Information
Base salary offered is determined through an analytical approach utilizing a combination of factors including, but not limited to, relevant skills & experience, job location, and internal equity.
Regular employees are eligible to receive both short term and long-term incentives, including cash bonus and equity incentive opportunities, designed to reward recent achievements and recognize your future potential based on individual, business unit and company performance.
In addition to compensation, Biogen offers a full and highly competitive range of benefits designed to support our employees’ and their families physical, financial, emotional, and social well-being; including, but not limited to:
- Medical, Dental, Vision, & Life insurances
- Fitness & Wellness programs including a fitness reimbursement
- Short- and Long-Term Disability insurance
- A minimum of 15 days of paid vacation and an additional end-of-year shutdown time off (Dec 26-Dec 31)
- Up to 12 company paid holidays + 3 paid days off for Personal Significance
- 80 hours of sick time per calendar year
- Paid Maternity and Parental Leave benefit
- 401(k) program participation with company matched contributions
- Employee stock purchase plan
- Tuition reimbursement of up to $10,000 per calendar year
- Employee Resource Groups participation
Why Biogen?
We are a global team with a commitment to excellence, and a pioneering spirit. As a mid-sized biotechnology company, we provide the stability and resources of a well-established business while fostering an environment where individual contributions make a significant impact. Our team encompasses some of the most talented and passionate achievers who have unparalleled opportunities for learning, growth, and expanding their skills. Above all, we work together to deliver life-changing medicines, with every role playing a vital part in our mission. Caring Deeply. Achieving Excellence. Changing Lives.
At Biogen, we are committed to building on our culture of inclusion and belonging that reflects the communities where we operate and the patients we serve. We know that diverse backgrounds, cultures, and perspectives make us a stronger and more innovative company, and we are focused on building teams where every employee feels empowered and inspired. Read on to learn more about our DE&I efforts.
All qualified applicants will receive consideration for employment without regard to sex, gender identity or expression, sexual orientation, marital status, race, color, national origin, ancestry, ethnicity, religion, age, veteran status, disability, genetic information or any other basis protected by federal, state or local law. Biogen is an E-Verify Employer in the United States.
Top Skills
Biogen Cambridge, Massachusetts, USA Office
225 Binney Street, Cambridge, MA, United States, 02142
Similar Jobs
What you need to know about the Boston Tech Scene
Key Facts About Boston Tech
- Number of Tech Workers: 269,000; 9.4% of overall workforce (2024 CompTIA survey)
- Major Tech Employers: Thermo Fisher Scientific, Toast, Klaviyo, HubSpot, DraftKings
- Key Industries: Artificial intelligence, biotechnology, robotics, software, aerospace
- Funding Landscape: $15.7 billion in venture capital funding in 2024 (Pitchbook)
- Notable Investors: Summit Partners, Volition Capital, Bain Capital Ventures, MassVentures, Highland Capital Partners
- Research Centers and Universities: MIT, Harvard University, Boston College, Tufts University, Boston University, Northeastern University, Smithsonian Astrophysical Observatory, National Bureau of Economic Research, Broad Institute, Lowell Center for Space Science & Technology, National Emerging Infectious Diseases Laboratories
